Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunomodulator”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04489628
What this trial is testing

Tele-health Enabled Clinical Trial for COVID-19

Who this might be right for
SARS-CoV Infection
University Hospitals Cleveland Medical Center
Very early researchStudy completedNCT00470379
What this trial is testing

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

Who this might be right for
Melanoma (Skin)
Mayo Clinic 30
Not applicableNot Yet RecruitingNCT06878495
What this trial is testing

Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease

Who this might be right for
Ulcerative Colitis (UC)Crohn's DiseaseInflammatory Bowel Disease (IBD)
Pusan National University Hospital 100
Not applicableActive Not RecruitingNCT03933826
What this trial is testing

CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer

Who this might be right for
Bladder CancerCancer of the Bladder, RecurrentNon-muscle Invasive Bladder Cancer
University of Washington 570
Large-scale testing (Phase 3)Study completedNCT00265226
What this trial is testing

Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

Who this might be right for
Tuberculosis
Ministry of Science and Technology, India 1,020
Testing effectiveness (Phase 2)UnknownNCT00856804
What this trial is testing

Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance

Who this might be right for
Hepatitis C
Valme University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01222338
What this trial is testing

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Who this might be right for
Tuberculosis
Lisichansk Regional Tuberculosis Dispensary 123
Testing effectiveness (Phase 2)Study completedNCT05829187
What this trial is testing

Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency

Who this might be right for
Uncomplicated Plasmodium Falciparum
Syamsudin Abdillah,Ph.D, Pharm D 36
Large-scale testing (Phase 3)Study completedNCT00347386
What this trial is testing

Therapeutic Zinc in Infant Bacterial Illness

Who this might be right for
SepsisBacterial InfectionsPneumonia
Centre For International Health 700
Not applicableUnknownNCT04920851
What this trial is testing

Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis

Who this might be right for
INTERLEUKIN 6
Derince Training and Research Hospital 23
Large-scale testing (Phase 3)Study completedNCT04317040
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 234
Testing effectiveness (Phase 2)Active Not RecruitingNCT06718101
What this trial is testing

Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 83
Testing effectiveness (Phase 2)UnknownNCT04309981
What this trial is testing

Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Sara V. Latorre 73
Not applicableLooking for participantsNCT06131775
What this trial is testing

Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer

Who this might be right for
All Types of Solid Cancer
Hospices Civils de Lyon 300
Not applicableEnded earlyNCT02838966
What this trial is testing

Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)

Who this might be right for
Pancreatic Adenocarcinoma
University of Louisville 14
Not applicableUnknownNCT01019837
What this trial is testing

Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics

Who this might be right for
Influenza H1N1
Tel-Aviv Sourasky Medical Center 200
Early research (Phase 1)Study completedNCT00004929
What this trial is testing

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 15
Not applicableActive Not RecruitingNCT00606346
What this trial is testing

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Who this might be right for
Crohn's DiseaseUlcerative ColitisIndeterminate Colitis+1 more
Janssen Biotech, Inc. 4,970
Testing effectiveness (Phase 2)UnknownNCT04941937
What this trial is testing

Selinexor in Combination With Immunomodulator (Thalidomide/Pomalidomide/Lenalidomide)in RRMM

Who this might be right for
Multiple Myeloma
Juan Du 90
Not applicableStudy completedNCT01793935
What this trial is testing

Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
K.N. Roy Chengappa 68
Next Page